Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02989389 · ClinicalTrials.gov registry record · Phase 1
A Study of LY3323795 in Healthy Participants
A Phase 1 study, sponsored by Eli Lilly and Company.
- Completed
- Registry status
- Phase 1
- Development phase
- 42
- Enrollment target
NCT02989389 is a Phase 1 study that has completed, run by Eli Lilly and Company. The registered enrollment target is 42 participants.
The verdict
NCT02989389, a Phase 1 study, has completed, sponsored by Eli Lilly and Company.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 42 participants
- Enrollment target
Study Summary
The main purpose of this study is to investigate the safety of LY3323795 and the effects it has on the body. The study drug or placebo (sugar pill) will be given by mouth to healthy participants. The study has three parts. Each participant may only enroll in one part. The study will last 14 to 43 days, depending on the part. Screening must be completed prior to study start.
Interventions
- DRUG Placebo
- DRUG Itraconazole
- DRUG LY3323795
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 42 participants |
| Start Date | 2016-12-12 |
| Est. Completion | 2017-07-21 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02989389
The ClinicalTrials.gov registry entry for NCT02989389 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 42 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Eli Lilly and Company, which has 1,341 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Placebo is the first listed.
NCT02989389 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02989389 about?
NCT02989389 is a clinical study titled "A Study of LY3323795 in Healthy Participants". The main purpose of this study is to investigate the safety of LY3323795 and the effects it has on the body. The study drug or placebo (sugar pill) will be given by mouth to healthy participants. The study has three parts. Each participant may only enroll in one part. The study will last 14 to 43 da...
What is the current status of trial NCT02989389?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 42 participants. The study started on 2016-12-12. Estimated completion is 2017-07-21.
What interventions are being tested in trial NCT02989389?
The interventions under investigation include: Placebo (DRUG), Itraconazole (DRUG), LY3323795 (DRUG).
Who is sponsoring clinical trial NCT02989389?
This trial is sponsored by Eli Lilly and Company, which has 1,341 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.